大参林: 大参林医药集团股份有限公司2025年第一次临时股东大会决议公告

Meeting Details - The shareholders' meeting was held on June 25, 2025, at the company's headquarters in Guangzhou [1] - The attendance rate of ordinary shareholders and preferred shareholders with restored voting rights was 76.7419% [1] - The meeting was convened by the board of directors and presided over by director Ke Guoqiang, following legal and procedural requirements [1] Voting Results - All non-cumulative voting proposals were approved, with 99.2431% of A-shareholders voting in favor [1] - The voting breakdown showed 862,239,871 votes in favor, 6,475,995 against, and 99,424 abstentions [1] Legal Compliance - The lawyers confirmed that the meeting's procedures complied with relevant laws and regulations, ensuring the legality of the attendees and the voting process [2]